Ledger.Open graph →
SEC Form D · Amendment · filed February 5, 2026

PathCision Medicine, Inc

Offering
$3.0M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Robert J. Peters · Dallas, TXExec · DirectorScott A. Williams · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗